Stephens Inc Glaukos Corp Transaction History

Stephens Inc

$6.84 Billion
Q4 2024

A detailed history of Stephens Inc transactions in Glaukos Corp stock. As of the latest transaction made, Stephens Inc holds 1,749 shares of GKOS stock, worth $178,852. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,749

Previous 1,797 2.67%

Holding current value

$178,852

Previous $234,000 11.97%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	SELL	$126.42 - $152.67 $6,068 - $7,328	-48 Reduced 2.67%	1,749 $262,000
Q3 2024 Oct 28, 2024	SELL	$113.62 - $135.39 $124,982 - $148,928	-1,100 Reduced 37.97%	1,797 $234,000
Q2 2024 Aug 06, 2024	SELL	$89.48 - $118.35 $536 - $710	-6 Reduced 0.21%	2,897 $342,000
Q1 2024 May 15, 2024	SELL	$76.4 - $96.33 $331,652 - $418,168	-4,341 Reduced 59.93%	2,903 $273,000
Q4 2023 Feb 13, 2024	SELL	$59.53 - $85.11 $384,028 - $549,044	-6,451 Reduced 47.1%	7,244 $575,000
Q3 2023 Nov 14, 2023	SELL	$69.23 - $79.09 $79,406 - $90,716	-1,147 Reduced 7.73%	13,695 $1.03 Million
Q2 2023 Aug 14, 2023	SELL	$45.44 - $71.21 $135,638 - $212,561	-2,985 Reduced 16.74%	14,842 $1.06 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $324,799 - $388,456	7,402 Added 71.0%	17,827 $893,000
Q4 2022 Jan 25, 2023	BUY	$40.82 - $57.75 $191,486 - $270,905	4,691 Added 81.81%	10,425 $455,000
Q3 2022 Nov 02, 2022	SELL	$46.84 - $58.49 $17,705 - $22,109	-378 Reduced 6.18%	5,734 $305,000
Q2 2022 Aug 03, 2022	SELL	$34.86 - $63.77 $11,120 - $20,342	-319 Reduced 4.96%	6,112 $278,000
Q1 2022 May 04, 2022	BUY	$44.33 - $57.82 $1,507 - $1,965	34 Added 0.53%	6,431 $372,000
Q4 2021 Mar 07, 2022	BUY	$40.27 - $56.99 $19,128 - $27,070	475 Added 8.02%	6,397 $284,000
Q3 2021 Oct 27, 2021	BUY	$47.43 - $84.23 $125,120 - $222,198	2,638 Added 80.33%	5,922 $285,000
Q2 2021 Aug 12, 2021	BUY	$73.06 - $97.7 $239,929 - $320,846	3,284 New	3,284 $279,000
Q3 2019 Oct 18, 2019	SELL	$58.58 - $83.91 $403,733 - $578,307	-6,892 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$63.59 - $78.71 $67,977 - $84,140	-1,069 Reduced 13.43%	6,892 $520,000
Q1 2019 May 03, 2019	BUY	$50.75 - $80.54 $404,020 - $641,178	7,961 New	7,961 $624,000
Q4 2018 Feb 11, 2019	SELL	$52.18 - $67.93 $168,332 - $219,142	-3,226 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $123,007 - $220,561	3,226 New	3,226 $209,000

Others Institutions Holding GKOS

# of Institutions

355

Shares Held

50.1M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $4.87B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account